New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ingredion to present new resistant starch research

Ingredion will present to scientists, physicians and dietitians gathered to discuss the latest research on the nutritional aspects of diabetes prevention and treatment.

Ingredion, a leading global provider of ingredient solutions to diversified industries, is sponsoring a scientific session, entitled “Reducing the Risk of Type 2 Diabetes: Improved Carbohydrate Metabolism with Resistant Starch,” at DNSG 2015—33rd International Symposium on Diabetes and Nutrition. The meeting will bring together the world’s top scientists, physicians and dietitians to showcase the latest research on the nutritional aspects of diabetes prevention and treatment.

The session, chaired by Christine Pelkman, PhD, senior nutrition scientist and clinical research manager at Ingredion, will highlight the work of four scientists exploring the benefits of resistant starch on carbohydrate metabolism. The researchers will review their investigations of the glycemic effects of a specific type of resistant starch—derived from a high-amylose maize (HAM-RS). This special resistant starch is a natural, nutritional ingredient that delivers four important benefits, including weight management, glycemic management, energy management and digestive health.   

Session highlights
Michael Keenan, PhD, Louisiana State University and Denise Robertson, PhD, University of Surrey, will give plenary lectures highlighting research on the effects of resistant starch on fat metabolism and insulin sensitivity—based on numerous studies they’ve conducted over the past two decades.

Barbara Gower, PhD, University of Alabama-Birmingham, will share the results of a recent clinical trial studying the effects of resistant starch on insulin sensitivity in women.

Maria Marco, PhD, University of California-Davis, will report on recent findings linking changes in gut microbiota with the metabolic benefits of resistant starch.

WHO: International scientists, physicians, dietitians, food manufacturers, formulators, and nutrition and food and beverage trade media

WHEN: 8:15–9:45 a.m. Thursday, June 11, 2015

• 8:15–8:35 a.m. Review of mechanisms – Findings from Animal Models (Michael Keenan, PhD)
• 8:35–8:55 a.m. Clinical evidence – Findings from human trials (Denise Robertson, PhD)
• 8:55–9:10 a.m. Oral Abstract  – Responders and non-responders – Baseline metabolic condition affects response to resistant starch (Barbara Gower, PhD)
• 9:10–9:25 a.m. Oral Abstract  – Linking microbial consumption of resistant starch to functional outcomes (Maria Marco, PhD)
• 9:25–9:45 a.m. Panel Discussion (Michael Keenan, PhD, Denise Robertson, PhD, Barbara Gower, Ph.D., Maria Marco, PhD)

DNSG 2015—33rd International Symposium on Diabetes and Nutrition
Intercontinental Toronto Yorkville Hotel
220 Bloor St. W.
Toronto, ON

WHY: To learn about the benefits of resistant starch on carbohydrate metabolism and how it can be used in functional foods

For more information on the DNSG 2015 scientific program, visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.